首页 | 本学科首页   官方微博 | 高级检索  
     

生物标志物应用于银屑病关节炎的研究进展
引用本文:李皓乾,张志强,李鹏翠,卫小春. 生物标志物应用于银屑病关节炎的研究进展[J]. 中华骨与关节外科杂志, 2021, 0(1): 76-80
作者姓名:李皓乾  张志强  李鹏翠  卫小春
作者单位:山西医科大学第二医院骨科骨与软组织损伤修复山西省重点实验室
摘    要:
银屑病是一种慢性的、免疫相关的炎症性疾病,20%~30%的银屑病患者最终会发展为银屑病关节炎(PsA),如果患者处于活动期,则可能出现关节破坏,最终致残.现阶段尚无用于PsA早期检测的有效手段,所以能发现用于早期诊断和治疗PsA的潜在生物标志物具有重要的临床意义,本文对此做一综述.

关 键 词:银屑病  银屑病关节炎  生物学标志物

Progress in the application of biomarkers to psoriatic arthritis
LI Haoqian,ZHANG Zhiqiang,LI Pengcui,WEI Xiaochun. Progress in the application of biomarkers to psoriatic arthritis[J]. Chinese Journal Bone and Joint Surgery, 2021, 0(1): 76-80
Authors:LI Haoqian  ZHANG Zhiqiang  LI Pengcui  WEI Xiaochun
Affiliation:(Department of Orthopaedics,The Second Hospital of Shanxi Medical University,Shanxi Key Laboratory of Bone and Soft Tissue Injury Repair,Taiyuan 030001,China)
Abstract:
Psoriasis is a chronic,immune-related inflammatory disease.20%-30%of patients with psoriasis eventually develop psoriatic arthritis(PsA),which may occur if the patient is in an active phase.The joints are destroyed and eventually become disabled.At present,there is no effective means to detect PsA early.So it is very important to find potential biomarkers for the early diagnosis and treatment of PsA.In this paper,we reviewed about it.
Keywords:Psoriasis  Psoriatic Arthritis  Biomarkers
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号